Drug Information

Drug General Information
Drug ID
D0SM0W
Former ID
DNCL003682
Drug Name
AN2728
Drug Type
Small molecular drug
Indication Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] Phase 3 [524726]
Company
Anacor Pharmaceuticals Inc.
Structure
Download
2D MOL
Formula
C14H10BNO3
PubChem Compound ID
44591583
Target and Pathway
Target(s) PDE4 Target Info Inhibitor [530489]
References
Ref 524726ClinicalTrials.gov (NCT02118792) Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis. U.S. National Institutes of Health.
Ref 530489AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009 Nov;10(11):1236-42.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.